$PFHO
PACIFIC HEALTH CARE ORGANIZATION INC

2023 Q2 Form 10-Q Financial Statement

#000118518523000557 Filed on May 18, 2023

View on sec.gov

Income Statement

Concept 2023 Q2 2023 Q1 2022 Q1
Revenue $1.299M $1.313M $1.427M
YoY Change -7.25% -8.04% 7.78%
Cost Of Revenue $267.4K $295.2K $237.6K
YoY Change 5.13% 24.24% 17.76%
Gross Profit $1.032M $1.017M $1.190M
YoY Change -10.0% -14.49% 5.99%
Gross Profit Margin 79.41% 77.51% 83.35%
Selling, General & Admin $877.1K $925.6K $923.5K
YoY Change -8.99% 0.23% -6.66%
% of Gross Profit 85.03% 90.97% 77.62%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $9.337K $9.379K $4.200K
YoY Change 0.43% 123.31% -66.72%
% of Gross Profit 0.91% 0.92% 0.35%
Operating Expenses $1.154M $1.230M $927.6K
YoY Change -5.99% 32.61% -7.42%
Operating Profit $145.1K $82.46K $262.1K
YoY Change -16.17% -68.54% 117.36%
Interest Expense $100.2K $99.82K $0.00
YoY Change -100.0%
% of Operating Profit 69.02% 121.06% 0.0%
Other Income/Expense, Net $30.75K $34.00K $10.19K
YoY Change -33.6% 233.71%
Pretax Income $245.3K $182.3K $262.1K
YoY Change 41.68% -30.46% -54.91%
Income Tax $68.85K $51.16K $73.57K
% Of Pretax Income 28.07% 28.07% 28.07%
Net Earnings $176.4K $131.1K $188.5K
YoY Change 41.68% -30.46% -62.83%
Net Earnings / Revenue 13.58% 9.99% 13.21%
Basic Earnings Per Share $0.01 $0.01 $0.01
Diluted Earnings Per Share $0.01 $0.01 $14.71K
COMMON SHARES
Basic Shares Outstanding 12.80M shares 12.80M shares 12.80M shares
Diluted Shares Outstanding 12.82M shares 12.82M shares 12.82M shares

Balance Sheet

Concept 2023 Q2 2023 Q1 2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $9.964M $10.84M $10.54M
YoY Change -4.28% 2.89% 6.35%
Cash & Equivalents $2.296M $1.995M $10.54M
Short-Term Investments $7.667M $8.848M
Other Short-Term Assets $240.8K $170.2K $106.3K
YoY Change 38.14% 60.07% 35.47%
Inventory
Prepaid Expenses $158.8K $170.2K
Receivables $863.4K $997.7K $802.3K
Other Receivables $3.000K $3.000K $58.40K
Total Short-Term Assets $11.07M $12.01M $11.51M
YoY Change -3.92% 4.42% 6.2%
LONG-TERM ASSETS
Property, Plant & Equipment $80.16K $88.24K $94.47K
YoY Change -16.68% -6.6% -73.84%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $7.110K $7.110K $33.39K
YoY Change -78.71% -78.71% 24.64%
Total Long-Term Assets $87.27K $136.5K $127.9K
YoY Change -32.66% 6.79% -67.04%
TOTAL ASSETS
Total Short-Term Assets $11.07M $12.01M $11.51M
Total Long-Term Assets $87.27K $136.5K $127.9K
Total Assets $11.16M $12.15M $11.63M
YoY Change -4.24% 4.44% 3.67%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $80.27K $227.3K $61.84K
YoY Change -24.67% 267.6% -36.98%
Accrued Expenses $344.3K $287.6K $366.6K
YoY Change 12.51% -21.55% -30.52%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $799.2K $676.0K $613.4K
YoY Change 57.54% 10.2% -29.34%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $0.00 $10.52K $0.00
YoY Change -100.0%
Total Long-Term Liabilities $0.00 $10.52K $0.00
YoY Change -100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $799.2K $676.0K $613.4K
Total Long-Term Liabilities $0.00 $10.52K $0.00
Total Liabilities $814.9K $702.2K $620.5K
YoY Change 58.39% 13.15% -29.87%
SHAREHOLDERS EQUITY
Retained Earnings $9.914M $11.02M
YoY Change -7.42%
Common Stock $12.80K $12.80K
YoY Change 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $10.34M $11.45M $11.01M
YoY Change
Total Liabilities & Shareholders Equity $11.16M $12.15M $11.63M
YoY Change -4.24% 4.44% 3.67%

Cashflow Statement

Concept 2023 Q2 2023 Q1 2022 Q1
OPERATING ACTIVITIES
Net Income $176.4K $131.1K $188.5K
YoY Change 41.68% -30.46% -62.83%
Depreciation, Depletion And Amortization $9.337K $9.379K $4.200K
YoY Change 0.43% 123.31% -66.72%
Cash From Operating Activities $308.2K -$41.38K $459.4K
YoY Change -359.13% -109.01% 10.82%
INVESTING ACTIVITIES
Capital Expenditures $1.260K $209.00 -$6.130K
YoY Change -111.41% -103.41% 89.78%
Acquisitions
YoY Change
Other Investing Activities $1.105M
YoY Change
Cash From Investing Activities $1.104M -$209.00 -$6.130K
YoY Change -10101.72% -96.59% 89.78%
FINANCING ACTIVITIES
Cash Dividend Paid $0.00
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -1.111M $0.00 0.000
YoY Change
NET CHANGE
Cash From Operating Activities 308.2K -$41.38K 459.4K
Cash From Investing Activities 1.104M -$209.00 -6.130K
Cash From Financing Activities -1.111M $0.00 0.000
Net Change In Cash 301.4K -$41.59K 453.2K
YoY Change -331.89% -109.18% 10.2%
FREE CASH FLOW
Cash From Operating Activities $308.2K -$41.38K $459.4K
Capital Expenditures $1.260K $209.00 -$6.130K
Free Cash Flow $306.9K -$41.59K $465.5K
YoY Change -384.48% -108.93% 11.43%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q1 dei Document Type
DocumentType
10-Q
CY2023Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q1 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2023Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q1 dei Entity File Number
EntityFileNumber
000-50009
CY2023Q1 dei Entity Registrant Name
EntityRegistrantName
PACIFIC HEALTH CARE ORGANIZATION, INC.
CY2023Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
UT
CY2023Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
87-0285238
CY2023Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
19800 MacArthur Boulevard, Suites 306 & 307
CY2023Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Irvine
CY2023Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
CY2023Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
92612
CY2023Q1 dei City Area Code
CityAreaCode
949
CY2023Q1 dei Local Phone Number
LocalPhoneNumber
721-8272
CY2023Q1 dei Security12b Title
Security12bTitle
None
CY2023Q1 dei Trading Symbol
TradingSymbol
N/A
CY2023Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q1 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023Q1 dei Entity Small Business
EntitySmallBusiness
true
CY2023Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023Q1 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
12800000 shares
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1994841 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2036432 usd
CY2023Q1 us-gaap Restricted Cash And Investments Current
RestrictedCashAndInvestmentsCurrent
8848251 usd
CY2022Q4 us-gaap Restricted Cash And Investments Current
RestrictedCashAndInvestmentsCurrent
8748435 usd
CY2023Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
8037 usd
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
7807 usd
CY2023Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
997731 usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
934990 usd
CY2023Q1 us-gaap Other Receivables
OtherReceivables
3000 usd
CY2022Q4 us-gaap Other Receivables
OtherReceivables
3000 usd
CY2023Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
170198 usd
CY2022Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
175355 usd
CY2023Q1 us-gaap Assets Current
AssetsCurrent
12014021 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
11898212 usd
CY2023Q1 us-gaap Property Plant And Equipment Other
PropertyPlantAndEquipmentOther
256709 usd
CY2022Q4 us-gaap Property Plant And Equipment Other
PropertyPlantAndEquipmentOther
256500 usd
CY2023Q1 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
20328 usd
CY2022Q4 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
20328 usd
CY2023Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
277037 usd
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
276828 usd
CY2023Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
188802 usd
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
179423 usd
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
88235 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
97405 usd
CY2023Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
41198 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
50137 usd
CY2023Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
7110 usd
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
6602 usd
CY2023Q1 us-gaap Assets
Assets
12150564 usd
CY2022Q4 us-gaap Assets
Assets
12052356 usd
CY2023Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
227322 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
263022 usd
CY2023Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
287563 usd
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
332551 usd
CY2023Q1 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
54295 usd
CY2022Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
3132 usd
CY2023Q1 us-gaap Loans Payable
LoansPayable
37000 usd
CY2022Q4 us-gaap Loans Payable
LoansPayable
37000 usd
CY2023Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
30681 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
39620 usd
CY2023Q1 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
39107 usd
CY2022Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
33544 usd
CY2023Q1 us-gaap Liabilities Current
LiabilitiesCurrent
675968 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
708869 usd
CY2023Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
10517 usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
10517 usd
CY2023Q1 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
15679 usd
CY2022Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
15679 usd
CY2023Q1 us-gaap Liabilities
Liabilities
702164 usd
CY2022Q4 us-gaap Liabilities
Liabilities
735065 usd
CY2023Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0 usd
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0 usd
CY2023Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2023Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
16000 shares
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
16000 shares
CY2023Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
16000 shares
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
16000 shares
CY2023Q1 us-gaap Preferred Stock Value
PreferredStockValue
16 usd
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
16 usd
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
800000000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
800000000 shares
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
12800000 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
12800000 shares
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
12800000 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
12800000 shares
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
12800 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
12800 usd
CY2023Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
416057 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
416057 usd
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
11019527 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
10888418 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
11448400 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
11317291 usd
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
12150564 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
12052356 usd
CY2023Q1 us-gaap Revenues
Revenues
1312643 usd
CY2022Q1 us-gaap Revenues
Revenues
1427383 usd
CY2023Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
9379 usd
CY2022Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
4195 usd
CY2023Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
230 usd
CY2022Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
4783 usd
CY2023Q1 us-gaap Professional And Contract Services Expense
ProfessionalAndContractServicesExpense
56254 usd
CY2022Q1 us-gaap Professional And Contract Services Expense
ProfessionalAndContractServicesExpense
53955 usd
CY2023Q1 us-gaap Labor And Related Expense
LaborAndRelatedExpense
662224 usd
CY2022Q1 us-gaap Labor And Related Expense
LaborAndRelatedExpense
633372 usd
CY2023Q1 us-gaap Professional Fees
ProfessionalFees
73102 usd
CY2022Q1 us-gaap Professional Fees
ProfessionalFees
66864 usd
CY2023Q1 us-gaap General Insurance Expense
GeneralInsuranceExpense
83481 usd
CY2022Q1 us-gaap General Insurance Expense
GeneralInsuranceExpense
83666 usd
CY2023Q1 us-gaap Other Cost Of Operating Revenue
OtherCostOfOperatingRevenue
177759 usd
CY2022Q1 us-gaap Other Cost Of Operating Revenue
OtherCostOfOperatingRevenue
143778 usd
CY2023Q1 us-gaap Other Expenses
OtherExpenses
34002 usd
CY2022Q1 us-gaap Other Expenses
OtherExpenses
10189 usd
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
133756 usd
CY2022Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
164472 usd
CY2023Q1 us-gaap Operating Expenses
OperatingExpenses
1230187 usd
CY2022Q1 us-gaap Operating Expenses
OperatingExpenses
1165274 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
82456 usd
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
262109 usd
CY2023Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
99816 usd
CY2022Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
0 usd
CY2023Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
99816 usd
CY2022Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
0 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
182272 usd
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
262109 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
51163 usd
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
73574 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
131109 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
188535 usd
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.01
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.01
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
12800000 shares
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
12800000 shares
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.01
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.01
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
12816000 shares
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
12816000 shares
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
10824405 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
188535 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
11012940 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
11317291 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
131109 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
11448400 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
131109 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
188535 usd
CY2023Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
9379 usd
CY2022Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
4195 usd
CY2023Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
230 usd
CY2022Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
4783 usd
CY2023Q1 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
99816 usd
CY2022Q1 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
0 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
62971 usd
CY2022Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-120930 usd
CY2023Q1 us-gaap Increase Decrease In Deferred Charges
IncreaseDecreaseInDeferredCharges
0 usd
CY2022Q1 us-gaap Increase Decrease In Deferred Charges
IncreaseDecreaseInDeferredCharges
14298 usd
CY2023Q1 us-gaap Increase Decrease In Deferred Liabilities
IncreaseDecreaseInDeferredLiabilities
5157 usd
CY2022Q1 us-gaap Increase Decrease In Deferred Liabilities
IncreaseDecreaseInDeferredLiabilities
14997 usd
CY2023Q1 us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
0 usd
CY2022Q1 us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
35620 usd
CY2023Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
508 usd
CY2022Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
6602 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-35700 usd
CY2022Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
16938 usd
CY2023Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-44988 usd
CY2022Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
51076 usd
CY2023Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
5563 usd
CY2022Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
5243 usd
CY2023Q1 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
51163 usd
CY2022Q1 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
109193 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-41382 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
459370 usd
CY2023Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
209 usd
CY2022Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
6133 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-209 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-6133 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
0 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
0 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-41591 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
453237 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2036432 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
10085372 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1994841 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
10538609 usd
CY2023Q1 us-gaap Interest Paid
InterestPaid
0 usd
CY2022Q1 us-gaap Interest Paid
InterestPaid
0 usd
CY2023Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
0 usd
CY2022Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
63000 usd
CY2023Q1 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
8037 usd
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
7807 usd
CY2022Q2 us-gaap Lessee Operating Lease Term Of Contract
LesseeOperatingLeaseTermOfContract
P12M
CY2023Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
42660 usd
CY2023Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
9903 usd
CY2023Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P1Y
CY2023Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0575 pure
CY2023Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
41198 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
50137 usd
CY2023Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
30681 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
39620 usd
CY2023Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
10517 usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
10517 usd
CY2023Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
41198 usd
CY2022Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
50137 usd
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
30681 usd
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
10517 usd
CY2023Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
41198 usd
CY2023Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
1462 usd
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
39736 usd
CY2023Q1 us-gaap Operating Lease Expense
OperatingLeaseExpense
9963 usd
CY2022Q1 us-gaap Operating Lease Expense
OperatingLeaseExpense
75584 usd
CY2023Q1 dei Amendment Flag
AmendmentFlag
false
CY2023Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001138476

Files In Submission

Name View Source Status
0001185185-23-000557-index-headers.html Edgar Link pending
0001185185-23-000557-index.html Edgar Link pending
0001185185-23-000557.txt Edgar Link pending
0001185185-23-000557-xbrl.zip Edgar Link pending
ex_522607.htm Edgar Link pending
ex_522608.htm Edgar Link pending
ex_522609.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
pacifichco20230331_10q.htm Edgar Link pending
pfho-20230331.xsd Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
pfho-20230331_cal.xml Edgar Link unprocessable
pfho-20230331_def.xml Edgar Link unprocessable
pfho-20230331_pre.xml Edgar Link unprocessable
pfho-20230331_lab.xml Edgar Link unprocessable
pacifichco20230331_10q_htm.xml Edgar Link completed